May 2025: This Month in Huntington’s Disease Research
From vision changes to genetic traffic jams and a clinical trial update, May was full of HD science excitement! Dive into our latest roundup to see how researchers are advancing Huntington’s disease in exciting new ways.
May was a month packed with exciting research, and we’ve got the highlights ready for you – no lab coat required! From genetic mysteries to vision changes and dental awareness, researchers uncovered some fascinating stuff about Huntington’s disease (HD) this month. And we heard an exciting clinical trial update from PTC Therapeutics. Buckle up for an abbreviated tour through the latest discoveries that are helping us learn more about HD and getting us closer to a treatment.
Assembly Line Breakdown: Protein Production Problems in Huntington’s Disease
New research put a spotlight on the world of protein production – and how things go a bit haywire in HD. A new study revealed that the mutant huntingtin protein doesn’t just misbehave on its own – it also messes with the cell’s entire protein-making factory.
Imagine a broken part clogging up the assembly line, causing chaos everywhere! In HD, even a little bit of this rogue protein can throw off the cell’s finely tuned quality control systems. The researchers also uncovered a tiny control switch in the HTT gene that might crank up the dysfunction even further. The big idea? Instead of just focusing on the toxic proteins themselves, maybe we can fix the machines they’re jamming up.
New research suggests heart-healthy habits are also good for your brain, as measured by the biomarker NfL that tracks with brain cell health. Older folks who had better cardiovascular health as they aged had less NfL, suggesting keeping your heart healthy is also good for your brain.
What’s Good for Your Heart is Good for Your Brain: New Study Links Cardiovascular Health to Brain Aging
There seems to be a connection between heart health and brain health. A new study revealed that following the American Heart Association’s “Life’s Simple 7” guidelines – like eating well, exercising, and managing blood pressure – not only benefits your heart but also tracks with lower levels of neurofilament light (NfL), a protein that tracks with brain health, can indicate brain cell damage and has become an important biomarker in HD research.
Specifically, participants with better cardiovascular health had significantly lower NfL levels, suggesting less neuronal damage. Over a decade, those with high heart health scores experienced a slower increase in NfL levels compared to those with lower scores. While the study didn’t find a similar connection with another biomarker, total tau , the findings underscore the potential of heart-healthy habits in protecting brain health, especially for those at risk of neurodegenerative diseases like Huntington’s.
Excitement and Anticipation as PTC’s Huntington’s Disease Drug Clears a Major Hurdle to Sprint Home
Perhaps the most exciting update from the month was the buzz-worthy news from the world of HD clinical trials! PTC Therapeutics’ daily pill, votoplam (formerly PTC-518), showed promising results in the Phase 2 PIVOT-HD clinical trial. The trial met its primary goal by effectively lowering levels of the huntingtin protein, a key strategy being explored in the clinic to treat HD. Importantly, votoplam demonstrated a favorable safety profile, with no serious adverse events reported.
Additionally (and certainly most excitingly!), early data suggest potential benefits in slowing disease progression, particularly in individuals with Stage 2 HD, as measured by some biomarkers and clinical assessments. While further analysis is needed, these findings advance hope for a new, convenient potential treatment option for the HD community.
The next steps here are for PTC to dig into the data more, then go over it with their new partner, Novartis. It’s not clear yet if they’ll use data they already have to seek accelerated approval from regulatory agencies or dive into a larger Phase 3 trial for votoplam. We’ll be watching closely and keep you updated as we learn more!
From genetic mysteries to vision changes and dental awareness, researchers uncovered some fascinating stuff about Huntington’s disease (HD) this month.
Navigating the Genetic River: How Tiny Variants Could Shift the Course of Huntington’s Disease
New work this month took us on a journey down the genetic river of the HD gene. Researchers discovered that tiny changes – like missing or duplicated genetic “dams” in the DNA sequence – can dramatically alter the river’s flow, potentially shifting the onset of HD symptoms by over a decade. These rare variations, known as Loss of Interruption (LOI) variants, affect the stability of the CAG and CCG repeat regions in the HTT gene.
While these genetic quirks are uncommon, they offer valuable insights into why some individuals develop HD earlier than expected, especially those in the diagnostic “gray zone” with intermediate repeat lengths between 27 and 29 CAGs. This research underscores the complexity of HD genetics and highlights the importance of understanding these subtle variations as we navigate toward more precise diagnostics and treatments.
Red Light, Green Light: How Huntington’s Disease Influences Genetic Traffic Lights
This month we took us on a ride through the genetic intersections of HD, revealing how the disease throws the cellular traffic system into chaos. Normally, our genes are regulated by epigenetic “traffic lights” – chemical signals that tell genes when to stop (red) or go (green).
In HD, these signals malfunction, causing some genes, especially those involved in early brain development, to get stuck on green when they should be red. This misregulation leads to neurons acting like they’re in a perpetual developmental phase, potentially accelerating brain aging and dysfunction.
The usual molecular “traffic cops,” PRC1 and PRC2, which are supposed to help maintain order, seem to be overwhelmed or replaced by less effective versions, making the problem worse. Understanding this epigenetic traffic jam opens new avenues for potential therapies aimed at restoring proper gene regulation and slowing disease progression.
Researchers found that subtle changes in visual memory may appear before classic Huntington’s disease symptoms. It’s not just about changes in eyesight – it’s how the brain processes what is seen, and early clues could help with diagnosis and daily support.
Unlocking the Mind’s Eye: How Huntington’s Disease Changes How We See and Process the World
Another study zoomed in on something we often take for granted: how our brains make sense of what we see. For people with HD, recognizing faces, reading a book, or even navigating a grocery store can get surprisingly tricky. Researchers in Spain ran a bunch of clever visual thinking tests, like drawing shapes from memory, to find out when and how these challenges pop up.
The plot twist? Subtle changes in visual memory might show up even before classic HD symptoms appear. This offers a chance for earlier diagnosis and better planning. Because it’s not just about what the eyes see, but how the brain interprets it. Spotting these shifts early could encourage people to use helpful visual reminders that could make a big difference in daily life.
DNA Repair in Huntington’s Disease: Not Up to Par?
More and more evidence is showing that HD influences DNA repair. A new study from Dr. Ray Truant’s team shows that expanded HTT slows production of a key DNA repair molecule called PAR, which usually flags damaged DNA. Without enough PAR, HD cells let damage pile up, possibly fueling the expansion of those nefarious CAG repeats that drive the disease.
The good news? Fixing the fixer might help. Getting HD cells up to par – by increasing PAR – could give cells the repair boost they need to fight back against disease progression. It’s early days, but this glitch in the repair crew might just point to a new way to keep Huntington’s in check.
Perhaps the most exciting update from the month was the buzz-worthy news from the world of HD clinical trials! PTC Therapeutics’ daily pill, votoplam (formerly PTC-518), showed promising results in the Phase 2 PIVOT-HD clinical trial.
Mind Your Mouth: Huntington’s Disease and Oral Health
HD can wreak havoc on oral health. A recent review reveals that people with HD face many dental challenges: movement issues make brushing a chore, dietary changes favor cavity-causing foods, and many dentists are unprepared for the unique needs of HD patients. Add in anxiety, financial strain, and mobility hurdles, and it’s no wonder dental care often gets sidelined.
But there’s hope! The article emphasizes that with the right knowledge and preparation, dental professionals can make a significant difference. By understanding HD’s impact and adapting care strategies, they can help patients maintain healthier smiles and improve their quality of life. The fact that this review was published is evidence that the word about HD is spreading amongst the dental community. So, let’s give a shout-out to those dentists ready to tackle HD’s dental dilemmas head-on – because everyone deserves a reason to smile.
The authors have no conflicts of interest to declare.
Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.
With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you’re able.
Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. More information…
